Painiv, SD units(lower scores indicate less pain) · people with recurrent corneal erosion syndrome without previous surgical intervention
1 finding from 1 review
Symptom score at 10 days. Measured on a 7‐point scale (0 to 6) ; lower score denotes fewer symptoms · acute asthma exacerbation
1 finding from 1 review
Overall survival: higher‐dose WBRT vs control (3000 cGy/10 daily fractions)No. of participants: 846(4 RCTs) · patients with newly diagnosed multiple brain metastases
Altered WBRT fractionation schedules probably leads to higher overall survival: lower‐dose WBRT vs control WBRT (3000 cGy/10 daily… compared with WBRT control (moderate certainty).
1 finding from 1 review
HR 1.21 [1.04, 1.4]
Studies not reported
Moderate
Neurological function improvement: lower‐dose WBRT vs control dose WBRT (3000 cGy/10 fractions)No. of participants: 1612(5 RCTs) · patients with newly diagnosed multiple brain metastases
Altered WBRT fractionation schedules probably leads to higher neurological function improvement: lower‐dose WBRT vs control dose… compared with WBRT control: neurological function improvement (moderate certainty).
1 finding from 1 review
OR 1.74 [1.06, 2.84]
Studies not reported
Moderate
Intervention not reported
Pain: 50% reduction in headache frequency Post‐treatment Lower scores = fewer headaches · Children and adolescents with chronic pain
It is very uncertain whether the intervention changes pain: 50% reduction in headache frequency Post‐treatment Lower… (very low certainty).
1 finding from 1 review
Intervention not reported
Disability Post‐treatment Lower scores = lower reported disability · Children and adolescents with chronic pain
1 finding from 1 review
Intervention not reported
Anxiety Post‐treatment Lower scores = lower reported anxiety · Children and adolescents with chronic pain
1 finding from 1 review
Intervention not reported
Depression Post‐treatment Lower scores = lower reported depression · Children and adolescents with chronic pain
1 finding from 1 review
Intervention not reported
Disability Post‐treatment Lower scores = lower reported disability · Children and adolescents with chronic pain
1 finding from 1 review
Intervention not reported
Anxiety Post‐treatment Lower scores = lower reported anxiety · Children and adolescents with chronic pain
1 finding from 1 review
Intervention not reported
Depression Post‐treatment Lower scores = lower reported depression · Children and adolescents with chronic pain
1 finding from 1 review
Intervention not reported
Pain Post‐treatment Lower scores = lower reported pain intensity · Children and adolescents with chronic pain
1 finding from 1 review
Depression (lower scores mean less depression) · clinical diagnosis of depression
1 finding from 1 review
Depression (lower scores mean less depression) · clinical diagnosis of depression
1 finding from 1 review
Any cancer risk No. of participants: 19,475 (3 RCTs) · Participants in trials with low risk of bias
Highest showed no clear difference in any cancer risk No. of participants: 19,475 (3 RCTs) compared with lowest selenium exposure (high certainty).
1 finding from 1 review
Cancer mortality risk No. of participants: 17,448 (1 RCT) · Participants in trials with low risk of bias
Highest showed no clear difference in cancer mortality risk No. of participants: 17,448 (1 RCT) compared with lowest selenium exposure (high certainty).
1 finding from 1 review
Colorectal cancer risk (16 studies) · Participants in trials with low risk of bias
Highest showed no clear difference in colorectal cancer risk No. of participants: 19,009 (2 RCTs) compared with lowest selenium exposure (high certainty).
1 finding from 1 review
Non‐melanoma skin cancer risk No. of participants: 2027 (2 RCTs) · Participants in trials with low risk of bias
Highest showed no clear difference in non‐melanoma skin cancer risk No. of participants: 2027 (2 RCTs) compared with lowest selenium exposure (moderate certainty).
1 finding from 1 review
Lung cancer risk (17 studies) · Participants in trials with low risk of bias
Highest showed no clear difference in lung cancer risk No. of participants: 19,009 (2 RCTs) compared with lowest selenium exposure (high certainty).
1 finding from 1 review
Breast cancer risk (14 studies) · Participants in trials with low risk of bias
Highest showed no clear difference in breast cancer risk No. of participants: 802 (1 RCT) compared with lowest selenium exposure (moderate certainty).
1 finding from 1 review